Skip to main content
Log in

Blood pressure and cardiovascular involvement in children with neurofibromatosis type1

  • Original Article
  • Published:
Pediatric Nephrology Aims and scope Submit manuscript

Abstract

We evaluated blood pressure in a sample of patients with neurofibromatosis type 1 (NF1), using ambulatory blood pressure monitoring (ABPM), to determine whether ABPM, when compared with casual BP recordings, allowed the detection of a higher risk for hypertension. We also evaluated the correlation between BP and vascular abnormalities. We studied 69 NF1 patients (36 males and 33 females) with a mean age of 11±4 years, divided into group A, with 24-h mean systolic blood pressure (SBP) or diastolic blood pressure (DBP) <95th percentile, and group B, with mean SBP or DBP >95th percentile. Standard electrocardiography and M-mode, two-dimensional echocardiography were performed and all patients were in sinus rhythm. ABPM identified 11 hypertensive patients (16%); 5 had a mean SBP >95th percentile, 3 mean SBP−DBP >95th percentile, and 3 a mean DBP >95th percentile. Laboratory and other investigations to exclude secondary hypertension were normal. Cardiac abnormalities were found in 13 of the 69 patients (18.8%) with NF1. There were no significant clinical and cardiac differences between the normotensive and hypertensive group. Our data emphasize the importance of periodic ABPM in NF1 patients to diagnose hypertension early and avoid target organ damage and increased mortality.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Riccardi VM (1981) Von Recklinghausen neurofibromatosis. N Engl J Med 27:1617–1627

    Google Scholar 

  2. Listernick R, Charrow J (1990) Neurofibromatosis type 1 in childhood. J Pediatr 16:845–851

    Google Scholar 

  3. Grifa A, Piemontese M, Meichionda R (1995) Screening of neurofibromatosis type 1 gene: identification of a large deletion and of an intronic variant. Clin Genet 47:281–284

    CAS  PubMed  Google Scholar 

  4. Garicochea B, Giorgi R, Odone VF, Dorihiac-Llacer PE, Bendit I (1998) Mutational analysis of N-RAS and GAP-related domain of the neurofibromatosis type 1 gene in chronic myelogenous leukaemia. Leuk Res 22:1003–1010

    Article  CAS  PubMed  Google Scholar 

  5. Riccardi VM (1992) Type 1 neurofibromatosis and the pediatric patient. Curr Probl Pediatr 22:66–106

    CAS  PubMed  Google Scholar 

  6. Wallace MR, Marcbuk DA, Andersen LB (1990) Type 1 neurofibromatosis gene: identification of a large transcript disrupted in three NF1 patients. Science 249:181–186

    CAS  PubMed  Google Scholar 

  7. Cawthon RM, Weiss M, Xu G, Viskochil D, Culver M, Stevens J, Robertson M, Dunn D, Gesteland R, O’Connell P (1990) A major segment of the neurofibromatosis type 1 gene: cDna sequence, genomic structure, and point mutations. Cell 62:193–201

    CAS  PubMed  Google Scholar 

  8. Viskochil D, Buchberg AM, Xu G, Cawthon RM, Stevens J, Wolff RK, Culver M, Carey JC, Copeland NG, Jenkins NA (1990) Deletions and a translocation interrupt a cloned gene at the neurofibromatosis type I locus. Cell 62:187–192

    CAS  PubMed  Google Scholar 

  9. Norton KK, Xu J, Gutmann DH (1995) Expression of the neurofibromatosis I gene product, neurofibromin, in blood vessel endothelial cells and smooth muscle. Neurobiol Dis 2:13–21

    Article  CAS  PubMed  Google Scholar 

  10. Lakkis MM, Epstein JA (1998) Neurofibromin modulation of ras activity is required for normal endocardial-mesenchymal transformation in the developing heart. Development 125:4359–4367

    CAS  PubMed  Google Scholar 

  11. Kurien A, Jhon PR, Milford DV (1997) Hypertension secondary to progressive vascular neurofibromatosis. Arch Dis Child 76:454–455

    CAS  PubMed  Google Scholar 

  12. Virdis R, Balestrazzi P, Zampolli M, Donadio A, Street M, Lorenzetti E (1994) Hypertension in children with neurofibromatosis. J Hum Hypertens 8:395–397

    CAS  PubMed  Google Scholar 

  13. Hirayama K, Kobayashi M, Yamaguchi N, Iwabuchi S, Gotoh M, Inoue C, Yamada S, Ebata H, Ishida H, Koyama A (1996) A case of renovascular hypertension associated with neurofibromatosis. Nephron 72:699–704

    CAS  PubMed  Google Scholar 

  14. Strauss S, Bistritzer T, Azizi E, Peer A, Morag B (1993) Renal artery stenosis secondary to neurofibromatosis in children: detection by Doppler ultrasound. Pediatr Nephrol 7:32–34

    CAS  PubMed  Google Scholar 

  15. Gutherie GP Jr (1982) Hypertension and neurofibromatosis. Hypertension 4:894−897

    PubMed  Google Scholar 

  16. Halpern M, Currarino G (1965) Vascular lesions causing hypertension in neurofibromatosis. N Engl J Med 273:248–252

    Google Scholar 

  17. Cappuccio FP, Allan R, Barron J, MacGregor GA, Murday VA (1999) Secondary hypertension and clinical genetics: usual presentation with unusual diagnosis. J Hum Hypertens 13:79–80

    Article  CAS  PubMed  Google Scholar 

  18. Weber MA (1988) Whole-day blood pressure. Hypertension 11:288–298

    CAS  PubMed  Google Scholar 

  19. Bald M, Kubel S, Rascher W (1994) Validity and reliability of 24 h blood pressure monitoring in children and adolescents using a portable, oscillometric device. J Hum Hypertens 8:363–366

    CAS  PubMed  Google Scholar 

  20. Baumgart P, Walger P, Gemen S, Von Eiff M, Raidt H, Rahn KH (1991) Blood pressure elevation during the night in chronic renal failure, hemodialisys and after renal transplantation. Nephron 57:293–298

    CAS  PubMed  Google Scholar 

  21. Calzolari A, Giordano U, Matteucci MC, Pastore E, Turchetta A, Rizzoni, Alpert B (1988) Hypertension in young patients after renal transplantation: ambulatory blood pressure monitoring versus casual blood pressure. Am J Hypertens 11:497–501

    Article  Google Scholar 

  22. Nishibata K, Nagashima M, Tsuji A, Hasegawa S, Nagai N, Goto M, Hayashi H (1995) Comparison of casual blood pressure and twenty-four-hour ambulatory blood pressure in high school students. J Pediatr 127:34–39

    CAS  PubMed  Google Scholar 

  23. Lin AE, Birch PH, Korf BR, Tenconi R, Niimura M, Poyhonen M, Armfield Uhas K, Sigorini M, Virdis R, Romano C, Bonioli E, Wolkenstein P, Pivnick EK, Lawrence M, Friedman JM (2000) Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1. Am J Med Genet 95:108–117

    Article  CAS  PubMed  Google Scholar 

  24. Stumpf DA, Alksne JF, Annegers JF, et al (1988) Neurofibromatosis Conference Statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575–578

    PubMed  Google Scholar 

  25. Lama G, Grassia C, Avino G, Esposito Salsano M, Calabrese E, Tarallo MR, Riccio V, Cantone D, Conforti R, Costagliola C, Melone MRAB, Scuotto A (1998) La neurofibromatosi tipo 1 in età pediatrica: 10 anni di esperienza. Riv Ital Pediatr 24:99–107

    Google Scholar 

  26. Schwartz GJ, Haycock GB, Edelmann CM, Spitzer A (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58:259–263

    CAS  PubMed  Google Scholar 

  27. Update on the 1987 Second Task Force Report on high blood pressure in children and adolescent: a working group report from the National High Blood Pressure Education Program (1996) Pediatrics 98:649–658

    PubMed  Google Scholar 

  28. Lurbe E, Redon J, Liao Y, Tacons J, Cooper RS, Alvarez V (1994) Ambulatory blood pressure monitoring in normotensive children. J Hypertens 12:1417–1423

    CAS  PubMed  Google Scholar 

  29. Mancia G, Sega R, Bravi C, Vito G de, Valagussa F, Cesana G, Zanchetti A (1995) Ambulatory blood pressure normality: results from the Pamela Study’s. J Hypertens 13:1377–1390

    CAS  PubMed  Google Scholar 

  30. Beltman FW, Heesen WF, Smit AJ, Lie KI, Meyboom-de jong B (1996) Acceptance and side effects of ambulatory blood pressure monitoring: evaluation of new technology. J Hum Hypertens 10 [Suppl 3]:S39–S42

    Google Scholar 

  31. Chandar JJ, Sfakianakis GN, Zilleruelo GE, Guerra JJ, Georgiou MF, Abibtol CL, Montane BS, Strauss J (1999) ACE inhibition scintigraphy in the management of hypertension in children. Pediatr Nephrol 13:493–500

    CAS  PubMed  Google Scholar 

  32. Devereux RB, Alonso DR, Lutas EM, Gottleib GJ, Campo E, Sachs I, Reichek N (1986) Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 57:450–458

    CAS  PubMed  Google Scholar 

  33. De Simone G, Daniels SR, Meyer RA, Roman MJ, De Divitiis O, Alderman MH (1992) Left ventricular mass and body size in normotensive children and adults: assessment of allometric relations and impact of overweight. J Am Coll Cardiol 20:1251–1260

    PubMed  Google Scholar 

  34. Alpert B, Daniels SR (1997) Twenty-four-hour ambulatory blood pressure monitoring: now that technology has come of age we need to catch up. J Pediatr 130:167–169

    CAS  PubMed  Google Scholar 

  35. Tilford DL, Kelsh RC (1973) Renal artery stenosis in childhood neurofibromatosis. Am J Dis Child 126:665–668

    CAS  PubMed  Google Scholar 

  36. Halpern M, Currarino G (1965) Vascular lesions causing hypertension in neurofibromatosis. N Engl J Med 273:248–252

    Google Scholar 

  37. Reubi F (1944) Les vaisseauex et les Glandes Endocrines dans la Neurofibromatose. Ztschr f Path u Bakt 7:168–236

    Google Scholar 

  38. Reubi F (1945) Neurofibromatose et Lesions Vasculaires. Schweiz Med Wochenschr 75:463–465

    Google Scholar 

  39. Green JF Jr, Fitzwater JE, Burgess J (1992) Arterial lesions associated with neurofibromatosis. Am J Clin Pathol 22:66–106

    Google Scholar 

  40. Salyer WR, Salyer DC (1974) The vascular lesions of neurofibromatosis. Angiology 25:510–519

    PubMed  Google Scholar 

  41. Lehrnbecher T, Gassel AM, Rauh V, Kirchner T, Huppertz HI (1994) Neurofibromatosis presenting as a severe systemic vasculopathy. Eur J Pediatr 153:107–109

    Article  CAS  PubMed  Google Scholar 

  42. Tedesco MA, Di Salvo G, Ratti G, Natale F, Calabrese E, Grassia C, Iacono A, Lama G (2001) Arterial distensibility and ambulatory blood pressure monitoring in young patients with neurofibromatosis type 1. Am J Hypertens 14:559–566

    Article  CAS  PubMed  Google Scholar 

  43. Tedesco MA, Di Salvo G, Natale F, Pergola V, Calabrese E, Grassia C, Ratti G, Iarussi D, Iacono A, Calabrò R, Lama G (2002) The heart in neurofibromatosis type 1: an echocardiographic study. Am Heart J 143:883–888

    Article  PubMed  Google Scholar 

  44. Zoller M, Rembeck B, Akesson HO, Angervall L (1995) Life exepectancy, mortality and prognostic factors in neurofibromatosis type 1. A twelve-year follow-up of an epidemiological study in Goteborg, Sweden. Acta Derm Venereol (Stockh) 75:136–140

    Google Scholar 

  45. Friedman JM, Arbiser J, Epstein JA, Gutmann DH, Huot SJ, Lin AE, McManus B, Korf BR (2002) Cardiovascular disease in neurofibromatosis 1: report of the NF1 Cardiovascular Task Force. Genet Med 4:105–111

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Giuliana Lama.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lama, G., Graziano, L., Calabrese, E. et al. Blood pressure and cardiovascular involvement in children with neurofibromatosis type1. Pediatr Nephrol 19, 413–418 (2004). https://doi.org/10.1007/s00467-003-1397-5

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00467-003-1397-5

Keywords

Navigation